Tsuyoshi Shimoboji

This inventor holds 13 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 10 EPO patents. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Tokyo Medical and Dental University, University of Washington. Active years: 2008-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsuyoshi Shimoboji. Retrieved from https://idiyas.com/inventor/tsuyoshi-shimoboji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 53.8

CIPO Patents = 1

EPO Patents = 10 (Patent Applications = 9)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 72(Granted Patents)

Location History:

Gotenba, JP (2008 - 2016)
Gotemba, JP (2022)
Shizuoka, JP (2009 - 2023)

Company Filing History:

12 out of 985

Chugai Seiyaku Kabushiki Kaisha

patents

2 out of 135

Tokyo Medical and Dental University

patents

1 out of 2,169

University of Washington

patents

where one patent can have more than one assignee

Years Active: 2008-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11564971 - Hyaluronic acid derivative having amino acid and steryl group introduced thereinto (2023-01-31),

2. 11512147 - Hyaluronic acid derivative modified with polyethylene glycol (2022-11-29),

3. 11389539 - Hyaluronic acid derivatives into which cationic and hydrophobic groups are introduced (2022-07-19),

4. 9394379 - Process for producing water-soluble hyaluronic acid modification (2016-07-19),

5. 9243077 - Derivative of hyaluronic acid modified with amino-carboxylic acid (2016-01-26),

6. 8987230 - Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same (2015-03-24),

7. 8759322 - Hyaluronic acid derivative and pharmaceutical composition thereof (2014-06-24),

8. 8575332 - Crosslinked polysaccharide microparticles and method for their preparation (2013-11-05),

9. 8143391 - Process for producing water-soluble hyaluronic acid modification (2012-03-27),

10. 7816316 - Sustained release drug carrier (2010-10-19),

11. 7767806 - Hyaluronic acid modification products and drug carriers using them (2010-08-03),

12. 7625764 - Stimuli-responsive polymer devices (2009-12-01),

13. 7456275 - Hyaluronic acid modification product (2008-11-25),

Title: Tsuyoshi Shimoboji: Innovator in Hyaluronic Acid Derivatives

Introduction

Tsuyoshi Shimoboji is a prominent inventor based in Gotenba, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of hyaluronic acid derivatives. With a total of 13 patents to his name, Shimoboji's work has advanced the understanding and application of these compounds in pharmaceuticals.

Latest Patents

Among his latest innovations, Shimoboji has developed a hyaluronic acid derivative that incorporates an amino acid and steryl group. This invention provides a unique hyaluronic acid derivative containing a disaccharide unit, which can be utilized in drug delivery systems. Another notable patent involves a hyaluronic acid derivative modified with polyethylene glycol. This invention includes various repeating units that introduce specific cationic, hydrophobic, and hydrophilic sites, enhancing the functionality of the derivatives in pharmaceutical compositions.

Career Highlights

Throughout his career, Tsuyoshi Shimoboji has worked with esteemed organizations such as Chugai Seiyaku Kabushiki Kaisha and Tokyo Medical and Dental University. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Shimoboji has collaborated with notable colleagues, including Teruo Nakamura and Tai Hirakura. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Tsuyoshi Shimoboji's innovative work in hyaluronic acid derivatives has made a significant impact in the field of pharmaceuticals. His contributions continue to influence drug delivery systems and enhance therapeutic applications.

Profile summary based on public USPTO records.